Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC

dc.contributor.authorSanz Sánchez, Tatiana
dc.contributor.authorGiménez Arnau, Ana María
dc.contributor.authorZaragoza Ninet, Violeta
dc.contributor.authorCórdoba Guijarro, Susana
dc.contributor.authorMiquel Miquel, Francisco Javier
dc.contributor.authorSilvestre Salvador, Juan Francisco
dc.contributor.authorGonzález Pérez, Ricardo
dc.contributor.authorRuiz González, Inmaculada
dc.contributor.authorMercader García, Pedro
dc.contributor.authorSerra Baldrich, Esther
dc.contributor.authorEt.al.
dc.date.accessioned2026-01-27T08:24:39Z
dc.date.available2026-01-27T08:24:39Z
dc.date.issued2025
dc.description.abstract2-Bromo-2-nitro-propane-1,3-diol (bronopol) is a formaldehyde releaser that was included as an emerging allergen needing to be evaluated in the European series in 2019, and as a candidate allergen for inclusion in the Spanish baseline series based on data from the Spanish Registry for Research in Dermatitis and Contact Allergy (REIDAC), in TRUE Test 0.25 mg/cm2 or 0.5% pet. in 2022. In a previous Spanish study, we perceived a frequency of sensitization to bronopol of 0.36% (15/4088) and we noted that the TRUE Test detected 13 of 15 overall reactions to bronopol. We found a current relevance of 6/13 in TRUE Test and none in petrolatum. However, one limitation of this work was that the data could not be directly compared because they came from different populations. The present study was then designed within REIDAC due to differences, with the aim of updating epidemological data regarding sensitizations to bronopol and evaluating discordant patch test reactions to bronopol.
dc.description.filiationUEMspa
dc.description.impact4.6 Q1 JCR 2024spa
dc.description.impact0.981 Q1 SJR 2024spa
dc.description.impactNo data IDR 2024spa
dc.description.sponsorshipFundación Piel Sana
dc.description.sponsorshipSpanish Agency for Medicines and Health Products
dc.description.sponsorshipSanofi and LeoPharma
dc.identifier.citationSánchez, T. S., Giménez‐Arnau, A. M., Ninet, V. Z., Guijarro, S. C., Miquel, F. J. M., Salvador, J. F. S., Pérez, R. G., González, I. R., Mercader‐García, P., Baldrich, E. S., Carrillo, J. M. C., Romero, F. T., De Frutos, F. J. O., Serna, M. R., Ortega, M. E. G., Suárez, C. P., Navarro‐Triviño, F., Chicharro, P., Nieto, M. A. P., … Borrego, L. (2025). Discordant patch test reactions to 2‐bromo‐2‐nitro‐propane‐1,3‐diol (Bronopol): A multicenter study from reidac. Contact Dermatitis, cod.70082. https://doi.org/10.1111/cod.70082
dc.identifier.doi10.1111/cod.70082
dc.identifier.issn0105-1873
dc.identifier.issn1600-0536
dc.identifier.urihttps://hdl.handle.net/11268/16765
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttps://doi.org/10.1111/cod.70082
dc.rights.accessRightsrestricted access
dc.subject.otherDermatitits
dc.subject.otherFormaldehído
dc.subject.otherErupciones por Medicamentos
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoQuímico farmacéutico
dc.subject.unescoEnfermedad de la piel
dc.subject.unescoInvestigación médica
dc.titleDiscordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Discordant Patch Test_2026.pdf
Size:
201.56 KB
Format:
Adobe Portable Document Format